Q4 2024 LifeVantage Corp Earnings Call Transcript
Key Points
- Adjusted EBITDA margin improved by 90 basis points to 9.8% compared to the previous year.
- Adjusted EBITDA for the full fiscal year increased by 45% to $17 million.
- Sequential revenue growth of 2.4% in the Americas region over fiscal Q3.
- Productivity improvements with a 2% increase in revenue per consultant year-over-year.
- Successful launch and positive reception of the TrueScience liquid collagen product.
- Total revenues for the quarter were down nearly 10% year-over-year.
- Currency adjusted revenue decreased by 8% for the quarter.
- Revenue in the Asia Pacific and Europe region decreased by 25.2%, with a 17.1% drop in total active accounts.
- Non-GAAP adjusted net income decreased to $1.8 million from $2.2 million in the prior year period.
- Income tax expense increased to $1.4 million from $600,000 in the prior year period.
Good day, ladies and gentlemen, thank you for standing by. Welcome to today's conference call to discuss LifeVantage's fourth quarter of fiscal 2024 results. (Operator Instructions) Hosting today's conference will be Reed Anderson with ICR. As a reminder, today's conference is being recorded. I would now like to turn the conference over to Mr. Anderson. Please go ahead sir.
Thank you. Good afternoon, and welcome to LifeVantage Corporation's conference call to discuss results for the fourth quarter of fiscal 2024. On the call today from LifeVantage with prepared remarks are Steve Fife, President and Chief Executive Officer; and Carl Aure, Chief Financial Officer.
By now everyone should have access to the earnings release which went out this afternoon at approximately 4:05 PM Eastern time. If you have not received the release, it is available on the investor relations portion of LifeVantage's website at www
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |